poisar

Stocks · News reference

Asimov and Emergent BioSolutions Announce Cell Line Development Partnership

Fiscal.ai

Emergent BioSolutions has entered into a partnership with Asimov to develop cell lines for two monoclonal antibodies targeting Ebola.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading